Currently used CA inhibitors are of non-selective effect with a considerable affinity to block tumor related isoenzyme CAIX and CAXII activity which could be specifically demonstrated in hypoxic cancer cells in vitro [17,18,19]. The gene discussed is CA9; the disease is cancer.